Skip to content
lifestyle.duovoltart.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Adaptive Biotechnologies
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
June 15, 2026
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
May 29, 2026
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
May 21, 2026
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
January 27, 2026
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 23, 2026
←
Previous Page
1
2